Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

LacertaMatrix

K-Number: K260218 · 2026-02-19

Decision Date2026-02-19
Product CodeKGN
DecisionSubstantially Equivalent

Device Summary

LacertaMatrix is the device name listed in this FDA 510(k) record. The listed applicant is Lacerta Life Sciences. It received FDA 510(k) clearance on 2026-02-19 under 510(k) number K260218. The device is classified under product code KGN. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the LacertaMatrix?

LacertaMatrix is a medical device that received FDA 510(k) clearance on 2026-02-19. The listed applicant is Lacerta Life Sciences. The 510(k) number is K260218.

When did LacertaMatrix receive FDA 510(k) clearance?

LacertaMatrix received FDA 510(k) clearance on 2026-02-19, under 510(k) number K260218.

Who is the listed applicant for LacertaMatrix?

The FDA 510(k) record lists Lacerta Life Sciences as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for LacertaMatrix?

The FDA product code for LacertaMatrix is KGN.

Related Devices (Code: KGN)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.